======= VPS35 ======= == Gene Information == * **Official Symbol**: VPS35 * **Official Name**: VPS35 retromer complex component * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55737|55737]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96QK1|Q96QK1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=VPS35&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20VPS35|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601501|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene belongs to a group of vacuolar protein sorting (VPS) genes. The encoded protein is a component of a large multimeric complex, termed the retromer complex, involved in retrograde transport of proteins from endosomes to the trans-Golgi network. The close structural similarity between the yeast and human proteins that make up this complex suggests a similarity in function. Expression studies in yeast and mammalian cells indicate that this protein interacts directly with VPS35, which serves as the core of the retromer complex. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |Vps35| |positive regulation of locomotion involved in locomotory behavior| |regulation of terminal button organization| |positive regulation of dopamine biosynthetic process| |regulation of dopamine biosynthetic process| |negative regulation of vacuolar transport| |negative regulation of late endosome to lysosome transport| |positive regulation of Wnt protein secretion| |mitochondrion to lysosome transport| |mitochondrion-derived vesicle| |mitochondrion-derived vesicle mediated transport| |negative regulation of protein catabolic process in the vacuole| |negative regulation of lysosomal protein catabolic process| |regulation of Wnt protein secretion| |regulation of late endosome to lysosome transport| |retromer, cargo-selective complex| |tubular endosome| |regulation of vacuolar transport| |positive regulation of dopamine receptor signaling pathway| |regulation of locomotion involved in locomotory behavior| |positive regulation of dopamine metabolic process| |positive regulation of catecholamine metabolic process| |voluntary musculoskeletal movement| |regulation of lysosomal protein catabolic process| |positive regulation of cellular amine metabolic process| |D1 dopamine receptor binding| |regulation of protein catabolic process in the vacuole| |mitochondrial fragmentation involved in apoptotic process| |negative regulation of protein homooligomerization| |neurotransmitter receptor transport, endosome to plasma membrane| |neurotransmitter receptor transport, endosome to postsynaptic membrane| |regulation of dopamine receptor signaling pathway| |endosome to plasma membrane protein transport| |positive regulation of cellular response to drug| |regulation of dendritic spine maintenance| |protein localization to endosome| |positive regulation of mitochondrial fission| |neurotransmitter receptor transport to plasma membrane| |neurotransmitter receptor transport to postsynaptic membrane| |negative regulation of protein oligomerization| |transcytosis| |establishment of protein localization to postsynaptic membrane| |regulation of protein homooligomerization| |retromer complex| |regulation of catecholamine metabolic process| |regulation of dopamine metabolic process| |regulation of mitochondrial fission| |retrograde transport, endosome to plasma membrane| |positive regulation of behavior| |regulation of presynapse assembly| |regulation of presynapse organization| |positive regulation of response to drug| |protein localization to postsynaptic membrane| |neurotransmitter receptor transport| |regulation of cellular response to drug| |receptor localization to synapse| |regulation of protein oligomerization| |musculoskeletal movement| |multicellular organismal movement| |protein destabilization| |regulation of postsynaptic membrane neurotransmitter receptor levels| |establishment of protein localization to plasma membrane| |lysosome organization| |lytic vacuole organization| |apoptotic mitochondrial changes| |protein localization to synapse| |regulation of behavior| |regulation of cellular amine metabolic process| |negative regulation of cellular protein catabolic process| |vesicle-mediated transport to the plasma membrane| |retrograde transport, endosome to Golgi| |synapse assembly| |presynapse| |regulation of postsynapse organization| |regulation of response to drug| |regulation of synapse assembly| |lysosomal transport| |negative regulation of cellular protein localization| |positive regulation of mitochondrion organization| |late endosome| |vacuole organization| |vesicle-mediated transport in synapse| |negative regulation of protein complex assembly| |negative regulation of protein catabolic process| |negative regulation of inflammatory response| |positive regulation of cellular protein catabolic process| |vacuolar transport| |positive regulation of canonical Wnt signaling pathway| |cytosolic transport| |regulation of macroautophagy| |positive regulation of Wnt signaling pathway| |regulation of mitochondrion organization| |protein localization to plasma membrane| |negative regulation of neuron death| |negative regulation of defense response| |endosome membrane| |mitochondrial transport| |positive regulation of protein catabolic process| |regulation of synapse organization| |regulation of synapse structure or activity| |endosomal transport| |protein localization to cell periphery| |regulation of cellular protein catabolic process| |lysosome| |postsynaptic density| |negative regulation of cellular catabolic process| |early endosome| |protein-containing complex localization| |establishment of protein localization to membrane| |synapse organization| |positive regulation of protein secretion| |endosome| |regulation of canonical Wnt signaling pathway| |regulation of protein stability| |positive regulation of peptide secretion| |lysosomal membrane| |negative regulation of catabolic process| |regulation of neuron death| |neuron projection| |regulation of autophagy| |regulation of inflammatory response| |glutamatergic synapse| |Wnt signaling pathway| |cell-cell signaling by wnt| |regulation of Wnt signaling pathway| |positive regulation of cellular catabolic process| |negative regulation of response to external stimulus| |neuronal cell body| |regulation of protein catabolic process| |positive regulation of secretion by cell| |positive regulation of protein transport| |cell surface receptor signaling pathway involved in cell-cell signaling| |positive regulation of catabolic process| |positive regulation of secretion| |mitochondrion organization| |regulation of protein complex assembly| |positive regulation of establishment of protein localization| |regulation of protein secretion| |protein localization to membrane| |negative regulation of transport| |regulation of peptide secretion| |regulation of cellular protein localization| |positive regulation of locomotion| |positive regulation of organelle organization| |regulation of plasma membrane bounded cell projection organization| |perinuclear region of cytoplasm| |viral process| |negative regulation of cellular component organization| |regulation of protein transport| |regulation of cell projection organization| |protein localization to organelle| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of defense response| |symbiotic process| |regulation of secretion| |interspecies interaction between organisms| |regulation of cellular catabolic process| |regulation of cellular localization| |apoptotic process| |regulation of nervous system development| |regulation of cellular component biogenesis| |regulation of locomotion| |positive regulation of transport| |regulation of catabolic process| |negative regulation of cell death| |intracellular protein transport| |regulation of protein localization| |negative regulation of cellular protein metabolic process| |programmed cell death| |regulation of anatomical structure morphogenesis| |cell death| |regulation of response to external stimulus| |negative regulation of protein metabolic process| |cell-cell signaling| |positive regulation of cellular component organization| |mitochondrion| |regulation of organelle organization| |positive regulation of developmental process| |regulation of response to stress| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |positive regulation of cellular protein metabolic process| |establishment of protein localization| |negative regulation of response to stimulus| |positive regulation of signal transduction| |regulation of cell death| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of cell communication| |positive regulation of signaling| |establishment of localization in cell| |nitrogen compound transport| |regulation of transport| |vesicle-mediated transport| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp465|Cannabidiol 13μM R08 exp465]]|-2.1| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|-2.06| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.97| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-1.96| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|-1.95| |[[:results:exp490|Hydroxychloroquine 30μM R08 exp490]]|-1.93| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|-1.91| |[[:results:exp218|A-395 10μM R05 exp218]]|-1.84| |[[:results:exp399|Salubrinal 20μM R07 exp399]]|-1.81| |[[:results:exp504|MK2206 4μM R08 exp504]]|-1.79| |[[:results:exp182|IU1-47 25μM R04 exp182]]|-1.76| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|-1.76| |[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|1.87| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.09| |[[:results:exp264|Arsenate 40μM R06 exp264]]|2.15| ^Gene^Correlation^ |[[:human genes:v:vps29|VPS29]]|0.595| |[[:human genes:v:vps26a|VPS26A]]|0.566| |[[:human genes:c:ccdc22|CCDC22]]|0.474| |[[:human genes:c:commd3|COMMD3]]|0.455| |[[:human genes:a:arpc2|ARPC2]]|0.428| |[[:human genes:c:commd5|COMMD5]]|0.424| |[[:human genes:m:mapkapk5|MAPKAPK5]]|0.419| |[[:human genes:c:ccdc47|CCDC47]]|0.415| |[[:human genes:o:odc1|ODC1]]|0.412| |[[:human genes:v:vps41|VPS41]]|0.411| |[[:human genes:a:ahcyl1|AHCYL1]]|0.408| Global Fraction of Cell Lines Where Essential: 43/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|4/28| |bone|1/26| |breast|2/33| |central nervous system|2/56| |cervix|0/4| |colorectal|2/17| |esophagus|0/13| |fibroblast|0/1| |gastric|2/16| |kidney|4/21| |liver|0/20| |lung|4/75| |lymphocyte|0/16| |ovary|2/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|3/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|4/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2543 * **Expression level (log2 read counts)**: 7.39 {{:chemogenomics:nalm6 dist.png?nolink |}}